Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending April 22, 2022 - Corrected V Refills

Drug Industry TRx: +0.7% w/w; +9.8% y/y

Vascepa
TRx 67,188; -3.5% (-2,465) w/w; -19.9% y/y
NRx 31,370; -3.0% (-970) w/w; -18.5% y/y
Ref 35,818; -4.0% (-1,495) w/w; -21.0% y/y

Lovaza (Generic & Brand)
TRx 62,380; +1.5% (+894) w/w; +1.8% y/y
NRx 31,520; +2.4% (+737) w/w; +2.8% y/y
Ref 30,860; +0.5% (+157) w/w; -0.2% y/y

Generic Vascepa
TRx 36,110; +16.5% (+5,109) w/w; As % of total V: 35.0%
NRx 20,617; +25.0% (+4,130) w/w; As % of total V: 39.7%
Ref 15,493; +6.7% (+979) w/w; As % of total V: 30.2%

Generic Vascepa by Manufacturer
Hikma - TRx 6,573; (+222) w/w; Generic share 18.2%; Total V share 6.7%
Reddy - TRx 18,282; (+4,758) w/w; Generic share 50.6%; Total V share 17.7%
Apotex - TRx 11,256; (+129) w/w; Generic share 31.2%; Total V share 10.9%

Vascepa + Generic Vascepa
TRx 103,298; +2.6% (+2,644) w/w; +9.2% y/y
NRx 51,987; +6.5% (+3,160) w/w; +17.2% y/y
Ref 51,311; -1.0% (-515) w/w; +2.2% y/y